Abstracts tagged "18FDG PET/CT scan"

Abstract Number: 383 • 2019 ACR/ARP Annual Meeting
Retroperitoneal Fibrosis- a Single Center Experience
Mert Oztas¹, Emir Cerme ², Izzet Altun ³ and Serdal Ugurlu ⁴, ¹Istanbul University-Cerrahpasa,Department of Medicine, Division of Rheumatology, Istanbul, Turkey, ²Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey, ³Mayo Clinic, Scottsdale, AZ, ⁴Istanbul University - Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, istanbul, Turkey
Background/Purpose: Idiopathic retroperitoneal fibrosis (iRPF) is a rare, chronic, progressive disorder of unknown etiology and characterized by the presence of inflammatory and fibrous retroperitoneal tissue…
Abstract Number: 755 • 2019 ACR/ARP Annual Meeting
A Novel Diagnostic Algorithm for Polymyalgia Rheumatica Using Three Musculoskeletal Sites on Whole Body PET/CT
Claire Owen¹, Aurora Poon ¹, Victor Yang ¹, Chris McMaster ¹, Sze Ting Lee ¹, David Liew ¹, Jessica Leung ¹, Andrew Scott ¹ and Russell Buchanan ¹, ¹Austin Health, Heidelberg, Victoria, Australia
Background/Purpose: PMR is associated with a pattern of abnormal 18F-Fluorodeoxyglucose (18F-FDG) uptake on whole body PET/CT that is increasingly recognised to correlate anatomically with inflammation…
Abstract Number: 756 • 2019 ACR/ARP Annual Meeting
A Volar Pattern of 18F-Fluorodeoxyglucose Uptake at the Hand on Whole Body PET/CT Predicts Glucocorticoid-Responsive Disease in Polymyalgia Rheumatica
Claire Owen¹, Aurora Poon ¹, Sze Ting Lee ¹, Chris McMaster ¹, Jessica Leung ¹, David Liew ¹, Andrew Scott ¹ and Russell Buchanan ¹, ¹Austin Health, Heidelberg, Victoria, Australia
Background/Purpose: Almost half of all patients diagnosed with PMR require a protracted duration of glucocorticoid therapy due to relapsing disease.(1) On whole body PET/CT, PMR…
Abstract Number: 770 • 2019 ACR/ARP Annual Meeting
Involvement of Iliofemoral and Axillary Arteries in PET-CT May Be Associated with Atherosclerotic Risk Factors in Takayasu’s Arteritis
Sema Kaymaz-Tahra¹, Salih Ozguven ², Ali Ugur Unal ³, Fatma Alibaz-Oner ⁴, Tunc Ones ², Tanju Yusuf Erdil ² and Haner Direskeneli ⁵, ¹Marmara University School of Medicine, Division of Rheumatology, Istanbul, Istanbul, Turkey, ²Marmara University Faculty of Medicine, Nuclear Medicine, Istanbul, Turkey, ³Marmara University Faculty of Medicine, Rheumatology, Istanbul, Turkey, ⁴Marmara University Faculty of Medicine,Department of Rheumatology,Istanbul,Turkey, Istanbul, Turkey, ⁵Marmara University, School of Medicine, Division of Rheumatology, Istanbul, Turkey
Background/Purpose: FDG-PET-CT is recommended as one of the imaging modalities for the diagnosis and monitoring of primary large-vessel vasculitis (LVV), such as Takayasu’s arteritis (TAK).…
Abstract Number: 1745 • 2019 ACR/ARP Annual Meeting
Exercise Improves Arterial Inflammation in Childhood-onset Takayasu Arteritis: A Randomized Controlled Trial
Camilla Astley¹, Gleice Clemente ², Maria Teresa Terreri ³, Camila Carneiro ⁴, Marcos lima ⁴, Carlos Buchpiguel ⁴, Hilton Leão Filho ⁴, Fernanda Lima ¹, Ana Lúcia Sá-Pinto ¹, Clovis Silva ⁵, Nadia Aikawa ⁶, Saulo Gil ¹, Hamilton Roschel ¹, Rosa Pereira ⁷ and Bruno Gualano ¹, ¹Division of Rheumatology, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, sao paulo, Sao Paulo, Brazil, ²ivision of Paediatric Rheumatology, Departament of Paediatrics, Universidade Federal de São Paulo, sao paulo, Sao Paulo, Brazil, ³Pediatric Rheumatology Unit, Universidade Federal de São Paulo, São Paulo, Brazil, ⁴Nuclear Medicine Institute, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, sao paulo, Sao Paulo, Brazil, ⁵Pediatric Rheumatology Unit, Hospital das Clinicas, Faculdade de Medicina da Universidade de Sao Paulo (HCFMUSP), Sao Paulo, Brazil., Sao Paulo, Brazil, ⁶Rheumatology Division, Hospital das Clinicas, Faculdade de Medicina da Universidade de Sao Paulo (HCFMUSP), Sao Paulo, Brazil., Sao Paulo, Brazil, ⁷Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, Sao Paulo, Brazil
Background/Purpose: Childhood-onset Takayasu Arteritis (c-TA) is a rare primary systemic vasculitis that affects aorta and its major branches. This condition is associated with reduced wall…
Abstract Number: 2671 • 2019 ACR/ARP Annual Meeting
PET/CT Vascular Findings at Baseline and Six Months in Patients with Newly Diagnosed Giant Cell Arteritis
Anthony Sammel¹, Edward Hsiao ¹, Geoff Schembri ¹, Elizabeth Bailey ¹, Katherine Nguyen ¹, Janice Brewer ¹, Beatrice Janssen ¹, Leslie Schrieber ¹, Peter Youssef ², Clare Fraser ³ and Rodger Laurent ¹, ¹Royal North Shore Hospital, Sydney, Australia, ²Royal Prince Alfred Hospital, Sydney, Australia, ³Save Sight Institute, Sydney, Australia
Background/Purpose: PET/CT is a useful modality to diagnose GCA but there is limited knowledge as to how inflammatory vascular findings evolve on follow-up scans. This…
Abstract Number: 2674 • 2019 ACR/ARP Annual Meeting
Clinical Symptoms and Associated Vascular Imaging Findings in Takayasu’s Arteritis Compared to Giant Cell Arteritis
Despina Michailidou¹, Joel S. Rosenblum ², Casey A. Rimland ³, Jamie Marko ⁴, Mark A. Ahlman ⁴ and Peter C. Grayson ⁵, ¹National Institute of Arthritis, Musculoskeletal and Skin Disease (NIAMS), Bethesda, MD, Division of Rheumatology, University of Washington, Seattle, WA, Seattle, WA, ²National Institute of Arthritis, Musculoskeletal and Skin Disease (NIAMS), Bethesda, MD, Bethesda, MD, ³National Institute of Arthritis, Musculoskeletal and Skin Disease (NIAMS), Bethesda, MD, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, Chapel Hill, NC, ⁴Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD, Bethesda, MD, ⁵National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health, Bethesda, MD, Bethesda, MD
Background/Purpose: Takayasu’s arteritis (TAK) and giant cell arteritis (GCA) are the two major forms of large vessel vasculitis. The study objectives were to compare clinical…
Abstract Number: 2684 • 2019 ACR/ARP Annual Meeting
Real-world Comparative Study of Methotrexate vs Tocilizumab in Patients with Giant Cell Arteritis with Large Vessel Involvement
DIANA PRIETO- PENA¹, Mónica Calderón-Goercke ², Javier Loricera ³, Javier Narváez ⁴, Elena Aurrecoechea ⁵, Ignacio Villa ⁶, Santos Castañeda ⁷, Catalina Gómez-Arango ⁸, Antonio Mera ⁹, Eva Perez Pampín ⁹, Vicente Aldasoro Caceres ¹⁰, N Alvarez Rivas ¹¹, N Fernandez Llanio ¹², María Álvarez del buergo ¹³, Luisa Marena-Rojas ¹⁴, Francisca Sivera ¹⁵, Eva Galindez-Agirregoikoa ¹⁶, Roser Solans-Laqué ¹⁷, Susana Romero-Yuste ¹⁸, Lara Sanchez-Bilbao ¹⁹, Iñigo Gonzalez-Mazon ¹, Isabel Martínez Rodríguez ²⁰, Ignacio Banzo ²⁰, Miguel Angel González-Gay ²¹ and Ricardo Blanco ¹⁹, ¹Rheumatology, Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain, ²Hospital Marqués de Valdecilla, Santander, Cantabria, Spain, ³Rheumatology Department. Hospital Marqués de Valdecilla, Santander, Cantabria, Spain, ⁴Rheumatology Department, Hospital Universitario de Bellvitge, Barcelona, Spain, Barcelona, Catalonia, Spain, ⁵Rheumatology Department. Hospital Sierrallana, Torrelavega, Spain, ⁶Hospital de Sierrallana, Torrelavega, Cantabria, Spain, ⁷Rheumatology Department, Hospital Universitario de la Princesa, IIS-Princesa, Madrid, Spain, Madrid, Spain, ⁸Hospital Alto Deba, Mondragon, Pais Vasco, Spain, ⁹Division of Rheumatology, Instituto de Investigación Sanitaria-Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain, Santiago de Compostela, Spain, ¹⁰Complejo Hospitalario de Navarra, Navarra, Navarra, Spain, ¹¹H. Lucus Augusti, Lugo, Spain, ¹²H. Arnau de Vilanova, Lerida, Spain, ¹³Hospital Río Carrión, Palencia, Castilla y Leon, Spain, ¹⁴Hospital La Mancha Centro, Alcázar de San Juan, Castilla-La Mancha, Spain, ¹⁵Hospital General Universitario de Elda, Elda, Spain, ¹⁶Hospital de Basurto, Bilbao, Pais Vasco, Spain, ¹⁷Department of Internal Medicine, Hospital Vall d'Hebron, Barcelona, Spain., Barcelona, Catalonia, Spain, ¹⁸Complejo Hospitalario Universitario Pontevedra, Pontevedra, Galicia, Spain, ¹⁹Rheumatology, Hospital Universitario Marques de Valdecilla, Santander, Spain, ²⁰Hospital Universitario Marqués de Valdecilla, Santander, Spain, ²¹Universidad de Cantabria and IDIVAL, Hospital Universitario Marqués de Valdecilla, Santander, Spain
Background/Purpose: Giant cell arteritis (GCA) is the most common large vasculitis in elderly patients. According to previous studies, 50% of patients with GCA in whom…
Abstract Number: 2687 • 2019 ACR/ARP Annual Meeting
Clinicopathologic Associations in a Large International Cohort of Patients with Giant Cell Arteritis
Michael Putman¹, K Bates Gribbons ², Anthea Craven ³, Cristina Ponte ⁴, Joanna Robson ⁵, Ravi Suppiah ⁶, Richard Watts ⁷, Raashid Luqmani ³, Peter Merkel ⁸, Amy Archer ⁹ and Peter C. Grayson ¹⁰, ¹Northwestern University, Chicago, ²National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, ³University of Oxford, Oxford, United Kingdom, ⁴Department of Rheumatology, Hospital de Santa Maria, Lisbon, Portugal, ⁵Faculty of Health and Applied Sciences, University of the West of England, Bristol, United Kingdom, ⁶Department of Rheumatology, Auckland District Health Board, Auckland, New Zealand, ⁷Norwich Medical School, University of East Anglia, Norwich, United Kingdom, ⁸University of Pennsylvania, Pennsylvania, ⁹Northwestern, Chicago, ¹⁰National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health, Bethesda, MD, Bethesda, MD
Background/Purpose: In addition to aiding in diagnosis, histopathologic findings from temporal artery biopsy (TAB) specimens in giant cell arteritis (GCA) may be valuable for their…
Abstract Number: 326 • 2019 ACR/ARP Annual Meeting
Cardiac Sarcoidosis Awareness: Are We Underdiagnosing?
Yvonne Lee¹, Patil Injean ¹ and Mehrnaz Hojjati ¹, ¹Loma Linda University Health, Loma Linda
Background/Purpose: Sarcoidosis, a multiorgan granulomatous disorder, may involve the heart at any time and often presents with cardiac conduction disturbances, heart failure, and sudden death.…
Abstract Number: 494 • 2018 ACR/ARHP Annual Meeting
Arterial Wall Inflammation Declines after 6 Months of Anti-Inflammatory Therapy with Methotrexate and/or Adalimumab in Rheumatoid Arthritis Patients
Annelies Blanken¹, Rabia Agca¹, Alexandre Voskuyl², Ronald Boellaard³, Conny van der Laken² and Michael Nurmohamed^2,4, ¹Amsterdam Rheumatology and immunology Center, Location Reade, Amsterdam, Netherlands, ²Amsterdam Rheumatology and immunology Center, Location VU University Medical Center, Amsterdam, Netherlands, ³Radiology and Nuclear Medicine, Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, Netherlands, ⁴Rheumatology, Amsterdam Rheumatology and immunology Center, Location Reade, Amsterdam, Netherlands
Background/Purpose: Patients with rheumatoid arthritis (RA) have an elevated cardiovascular (CV) disease risk, mostly explained by both an increased prevalence of traditional CV risk factors…
Abstract Number: 2197 • 2018 ACR/ARHP Annual Meeting
Steroid Bolus Leads to a Negative 18f-FDG PET/CT Scan in Large Vessel Vasculitis. Data from a Multicenter Giant Cell Arteritis Cohort Database
Paula Estrada¹, Patricia Moya², Hector Corominas³, Delia Reina⁴, Dacia Cerdà⁴, Daniel Roig Vilaseca⁴, Vanessa Navarro⁴, Sergi Heredia⁴ and Francisco Javier Narváez⁵, ¹Rheumatology, Hospital Moisès Broggi-Hospital General de L´Hospitalet. Consorci Sanitari Integral, Barcelona, Spain, ²Rheumatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, ³Rheumatology, Hospital Universitari de la Santa Creu i Sant Pau, Barcelona, Spain, ⁴Rheumatology, Hospital Moisès Broggi-Hospital General de L´Hospitalet. Consorci Sanitari Integral,, barcelona, Spain, ⁵Rheumatology Department, Hospital de Bellvitge. Barcelona. Spain, L’Hospitalet de Llobregat, Spain
Background/Purpose: Giant cell arteritis (GCA) and polymialgia rheumatica (PMR) are overlapping inflammatory diseases. Large Vessel Vasculitis (LVV) is frequently present in any of the two…
Abstract Number: 2203 • 2018 ACR/ARHP Annual Meeting
Atherosclerotic Inflammation in Rheumatoid Arthritis Patients: A Post-Hoc Study Using Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography
Yukio Yonemoto¹, Masahiro Tachibana², Koichi OKAMURA¹, Takahito SUTO¹, Hideo SAKANE¹, Chisa OKURA¹, Tetsuya Kaneko² and Hirotaka CHIKUDA¹, ¹Orthopaedic Surgery, Gunma University Graduate School of Medicine, MAEBASHI, Japan, ²Orthopaedic Surgery, Gunma University Graduate School of Medicine, Maebashi, Japan
Background/Purpose: Rheumatoid arthritis (RA) has long been associated with an increased cardiovascular risk, and despite substantial improvements in disease management, its associated mortality remains high.…
Abstract Number: 2003 • 2017 ACR/ARHP Annual Meeting
18 FDG PET/CT Predicts Decline in Functional Respiratory TESTS in Systemic Sclerosis Patients but NOT in Rheumatoid Arthritis Patients
Jorge Juan Fragio Gil¹, Jose Ivorra Cortes¹, Manuela Martinez Frances², Jose Luis Loaiza Gongora³, Juan José Alegre⁴, Marta Garijo Bufort⁵, Susana Herrera Lara⁶, Inmaculada Chalmeta Verdejo¹, Luis Gonzalez Puig¹, Rosa Negueroles Albuixech¹, Cristina Alcañiz Escandell¹, Karla Arevalo Ruales¹, Ines Canovas Olmos¹, Carlos Feced Olmos¹, Roxana Gonzalez Mazario¹, Elena Grau Garcia¹, Eztizen Labrador Sanchez¹, Isabel Martinez Cordellat¹, Carmen Najera Herranz¹, Jose Eloy Oller Rodriguez¹, Francisco Miguel Ortiz-Sanjuán¹, Elvira Vicens Bernabeu¹, Marta De la Rubia Navarro¹, David Hervás Marín⁷ and Jose Andres Roman Ivorra¹, ¹Rheumatology Department. Hospital Universitario y Politecnico La Fe, Valencia, Spain, ²Pneumology Department. Hospital Universitario y Politecnico La Fe, Valencia, Spain, ³Nuclear Medicine Department. HUP La Fe, Valencia, Spain, ⁴Sección de Reumatología Hospital Universitario Dr Peset Valencia, Valencia, Spain, ⁵Rheumatology Unit. Hospital de León, León, Spain, ⁶Pneumology Department. Hospital Dr. Peset, Valencia, Spain, ⁷Biostatistics Unit. IIS La Fe, Valencia, Spain
Background/Purpose: Interstitial lung diseases (ILD) are a group of illnesses that often complicate connective tissue diseases (CTD) such as rheumatoid arthritis (RA) or systemic sclerosis…
Abstract Number: 1318 • 2015 ACR/ARHP Annual Meeting
Prediction of Large Joint Destruction in Patients with Rheumatoid Arthritis Using FDG-PET/CT: A Prospective Study
Takahito Suto, Koichi Okamura, Yukio Yonemoto, Chisa Okura and Kenji Takagishi, Department of Orthopaedic Surgery, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
Background/Purpose: The assessments of joint damage in patients with rheumatoid arthritis (RA) are mainly restricted to small joints in the hands and feet. However, the…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].